Study | Follow-Up | Outcome | Risk in Invasive Group (n/N) | Risk in Selective Group (n/N) | Relative Risk (95% CI) | p-value |
---|---|---|---|---|---|---|
PRAGUE[17] | 12 Months | Death/Non-Fatal Reinfarction | 18/100 | 30/99 | 0.59 (0.36, 0.99) | 0.04‡ |
 |  | Death | 12/100 | 18/99 | 0.66 (0.34, 1.30) | 0.22‡ |
 |  | Non-Fatal Reinfarction | 6/100 | 12/99 | 0.50 (0.19, 1.27) | 0.13‡ |
SIAM-3[18] | 6 Months†| CABG | 6/82 | 6/81 | 0.99 (0.33, 2.94)‡ | 0.609 |
 |  | TLR | 16/82 | 19/81 | 0.83 (0.46, 1.50)‡ | 0.336 |
 |  | Ischemic Events | 4/82 | 23/81 | 0.17 (0.06, 0.47)‡ | 0.001 |
 |  | Reinfarction | 2/82 | 2/81 | 0.99 (0.14, 6.84)‡ | 0.685 |
 |  | Death | 4/82 | 9/81 | 0.44 (0.14, 1.37)‡ | 0.119 |
 |  | Death/Reinfarction | 6/82 | 11/81 | 0.54 (0.21, 1.39)‡ | 0.146 |
 |  | Death/Reinfarction/TLR | 20/82 | 29/81 | 0.68 (0.42, 1.10)‡ | 0.078 |
 |  | Death/Reinfarction/TLR/Ischemic Events* | 21/82 | 41/81 | 0.51 (0.33, 0.78)‡ | 0.001 |
 | 6 Months††| CABG | 12/94 | 19/103 | 0.69 (0.36, 1.35)‡ | 0.185 |
 |  | TLR | 22/94 | 31/103 | 0.78 (0.49, 1.24)‡ | 0.185 |
 |  | Ischemic Events | 7/94 | 28/103 | 0.27 (0.13, 0.60)‡ | 0.001 |
 |  | Reinfarction | 3/94 | 3/103 | 1.10 (0.23, 5.30)‡ | 0.614 |
 |  | Death | 4/94 | 9/103 | 0.49 (0.16, 1.53)‡ | 0.164 |
 |  | Death/Reinfarction | 7/94 | 12/103 | 0.64 (0.27, 1.56)‡ | 0.225 |
 |  | Death/Reinfarction/TLR | 26/94 | 41/103 | 0.69 (0.46, 1.04)‡ | 0.049 |
 |  | Death/Reinfarction/TLR/Ischemic Events | 28/94 | 55/103 | 0.56 (0.39, 0.80)‡ | 0.001 |
GRACIA-1[19] | 12 Months | Death | 9/248 | 16/251 | 0.55 (0.22, 1.36) | 0.16 |
 |  | Non-Fatal Reinfarction | 9/248 | 15/251 | 0.60 (0.27, 1.36) | 0.22 |
 |  | Death/Non-Fatal Reinfarction | 17/248 | 29/251 | 0.59 (0.33, 1.05) | 0.07 |
 |  | Revascularization | 9/248 | 30/251 | 0.30 (0.15, 0.62) | 0.001 |
 |  | Readmission due to Ischemia | 37/248 | 62/251 | 0.60 (0.42, 0.87) | 0.006 |
 |  | Death/Non-Fatal Reinfarction/Revascularization* | 23/248 | 51/251 | 0.44 (0.28, 0.70) | 0.0008 |
CAPITAL-AMI[20] | 6 Months | Death/Recurrent MI/Recurrent Unstable Ischemia, Stroke* | 10/86 | 20/84 | 0.48 (0.24, 0.96) | 0.04 |
 |  | Death | 3/86 | 3/84 | 0.95 (0.20, 4.59) | 1.00 |
 |  | Reinfarction | 5/86 | 12/84 | 0.40 (0.15, 1.08) | 0.07 |
 |  | Recurrent Unstable Ischemia | 7/86 | 17/84 | 0.39 (0.17, 0.90) | 0.03 |
 |  | Stroke | 1/86 | 1/84 | 0.95 (0.60, 14.99) | 1.00 |
 |  | Death/Reinfarction/Stroke | 8/86 | 15/84 | 0.51 (0.23, 1.14) | 0.12 |
Leipzig[23] | 6 Months | Death | 5/82 | 6/82 | 0.83 (0.22, 2.99) | 0.68Â¥ |
 |  | Death/Reinfarction/Stroke/Major Bleeding | 12/82 | 21/82 | 0.57 (0.28, 1.13) | 0.10¥ |
TRANSFER AMI[27] | 6 Months | Death | 30/528 | 23/511 | 1.27 (0.77, 2.23) | 0.39 |
 |  | Reinfarction | 21/528 | 33/511 | 0.60 (0.34, 1.05) | 0.07 |
 |  | Death/Reinfarction | 47/528 | 54/511 | 0.83 (0.55, 1.25) | 0.36 |
NORDISTEMI[28] | 12 Months | Death/Reinfarction/Stroke/New Ischemia* | 28/134 | 36/132 | 0.77 (0.50, 1.18)‡ | 0.22‡ |
 |  | Death/Reinfarction/Stroke | 8/134 | 21/132 | 0.38 (0.17, 0.82)‡ | 0.008‡ |
 |  | Death | 3/134 | 4/132 | 0.74 (0.17, 3.24)‡ | 0.72‡ |
 |  | Reinfarction | 4/134 | 12/132 | 0.33 (0.11, 0.99)‡ | 0.04‡ |
 |  | Stroke | 3/134 | 7/132 | 0.42 (0.11, 1.60)‡ | 0.22‡ |
 |  | Recurrent Ischemia | 20/134 | 20/132 | 0.99 (0.56, 1.74)‡ | 0.96‡ |